Authors:
ORLANDI E
LAZZARINO M
BERNASCONI P
ASTORI C
BERNASCONI C
Citation: E. Orlandi et al., SECONDARY ACUTE MYELOID-LEUKEMIA FOLLOWING TREATMENT WITH VP16-CONTAINING REGIMENS FOR NON-HODGKINS-LYMPHOMA, Haematologica, 83(8), 1998, pp. 758-759
Authors:
ALESSANDRINO EP
BERNASCONI P
CALDERA D
COLOMBO A
MALCOVATI L
MARTINELLI G
BONFICHI M
PAGNUCCO G
ASTORI C
SALVANESCHI L
BERNASCONI C
Citation: Ep. Alessandrino et al., IMPROVING GVL BY CHEMOTHERAPY AND DONOR PBPC IN AL RELAPSED AFTER ALLO-BMT, Bone marrow transplantation, 21, 1998, pp. 242-242
Authors:
BONFICHI M
ASTORI C
PAGNUCCO G
ALESSANDRINO EP
CASTAGNOLA C
BRUSAMOLINO E
BERNASCONI P
BALDUINI A
MARSEGLIA C
VANELLI L
BERNASCONI C
Citation: M. Bonfichi et al., EVALUATION OF CIRCULATING HEMATOPOIETIC PROGENITORS MOBILIZED WITH CYCLO-PHOSPHAMIDE 4 GR M(2) OR 7 GR/M(2)/, Bone marrow transplantation, 21, 1998, pp. 672-672
Authors:
BONFICHI M
ALESSANDRINO EP
BERNASCONI P
PAGNUCCO G
VANELLI L
ASTORI C
MARSEGLIA C
BERNASCONI C
Citation: M. Bonfichi et al., KINETICS OF PERIPHERAL HEMATOPOIETIC PROGENITORS IN HEALTHY DONORS AFTER BONE-MARROW HARVEST, Bone marrow transplantation, 21, 1998, pp. 823-823
Authors:
BERNASCONI P
CAVIGLIANO PM
GENINI E
CASTAGNOLA C
MALCOVATI L
CALATRONI S
CARESANA M
BONI M
ALESSANDRINO EP
ASTORI C
CORSO A
BERNASCONI C
Citation: P. Bernasconi et al., A COMPLEX TRANSLOCATION(5-7) IN A PATIENT WITH ACUTE NONLYMPHOCYTIC LEUKEMIA EVOLVED FROM A MYELODYSPLASTIC SYNDROME, Cancer genetics and cytogenetics, 105(2), 1998, pp. 182-186
Authors:
LAZZARINO M
ORLANDI E
KLERSY C
ASTORI C
BRUSAMOLINO E
CORSO A
BELLIO L
GARGANTINI L
MORRA E
BERNASCONI C
Citation: M. Lazzarino et al., SERUM CA-125 IS OF CLINICAL-VALUE IN THE STAGING AND FOLLOW-UP OF PATIENTS WITH NON-HODGKINS-LYMPHOMA - CORRELATION WITH TUMOR PARAMETERS AND DISEASE-ACTIVITY, Cancer, 82(3), 1998, pp. 576-582
Authors:
ORLANDI E
LAZZARINO M
BRUSAMOLINO E
PAULLI M
ASTORI C
MAGRINI U
BERNASCONI C
Citation: E. Orlandi et al., NODULAR LYMPHOCYTE PREDOMINANCE HODGKINS-DISEASE - LONG-TERM OBSERVATION REVEALS A CONTINUOUS PATTERN OF RECURRENCE, Leukemia & lymphoma, 26(3-4), 1997, pp. 359-368
Authors:
BERNASCONI P
CAVIGLIANO PM
GENINI E
ALESSANDRINO EP
COLOMBO A
KLERSY C
MALCOVATI L
BIAGGI G
MARTINELLI G
CALATRONI S
CARESANA M
BONI M
ASTORI C
BERNASCONI C
Citation: P. Bernasconi et al., ASSESSMENT OF CHIMERISM IN SEX-MISMATCHED ALLOGENEIC BONE-MARROW TRANSPLANTS (ALLO-BMT) BY IN-SITU HYBRIDIZATION AND CYTOGENETICS - IS HOST-CELL PERCENTAGE PREDICTIVE OF RELAPSE, Leukemia, 11(11), 1997, pp. 1989-1990
Authors:
BERNASCONI P
CAVIGLIANO PM
GENINI E
BONI M
MALCOVATI L
CALATRONI S
CARESANA M
ALESSANDRINO EP
COLOMBO A
ASTORI C
BERNASCONI C
Citation: P. Bernasconi et al., IS FISH MORE EFFECTIVE THAN CYTOGENETICS IN DETECTING CHROMOSOME-5 ABNORMALITIES IN MDS ANLL/, Experimental hematology, 25(8), 1997, pp. 457-457
Authors:
ASTORI C
BONFICHI M
PAGNUCCO G
BERNASCONI P
LAZZARINO M
ORLANDI E
BERNASCONI C
Citation: C. Astori et al., TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) IN A PATIENTWITH PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - EVALUATION OF MEMBRANE-PROTEINS CD55 AND CD59 WITH CYTOFLUOROMETRIC ASSAY, British Journal of Haematology, 97(3), 1997, pp. 586-588
Authors:
BERNASCONI P
CAVIGLIANO PM
GENINI E
BONI M
CALATRONI S
MALCOVATI L
ALESSANDRINO EP
CALDERA D
COLOMBO A
MARTINELLI G
BIAGGI G
ASTORI C
BERNASCONI C
Citation: P. Bernasconi et al., MINIMAL RESIDUAL DISEASE (MRD) MONITORING IN PH-1 POSITIVE ALL SUBMITTED TO ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO-BMT), Blood, 90(10), 1997, pp. 3671-3671
Authors:
BONFICHI M
ASTORI C
BALDUINI A
ALESSANDRINO EP
BERNASCONI P
PAGNUCCO G
VANELLI L
MARSEGLIA C
BERNASCONI C
Citation: M. Bonfichi et al., HEMATOPOIETIC PROGENITOR EVALUATION IN HEALTHY DONORS BEFORE AND AFTER BONE-MARROW HARVESTING, Blood, 90(10), 1997, pp. 4203-4203
Authors:
ORLANDI E
LAZZARINO M
BERNASCONI P
BRUSAMOLINO E
PAGNUCCO G
ASTORI C
BERNASCONI C
Citation: E. Orlandi et al., SECONDARY ACUTE MYELOID-LEUKEMIA (SAL) FOLLOWING TREATMENT WITH ETOPOSIDE-CONTAINING REGIMENS FOR NON-HODGKINS-LYMPHOMA, Blood, 90(10), 1997, pp. 348-348
Authors:
LAZZARINO M
ORLANDI E
MONTILLO M
TEDESCHI A
PAGNUCCO G
ASTORI C
CRUGNOLA M
GARGANTINI L
CORSO A
BRUSAMOLINO E
MORRA E
BERNASCONI C
Citation: M. Lazzarino et al., FLUDARABINE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (FLUCYD) FOR THE TREATMENT OF ADVANCED LOW-GRADE NON-HODGKINS-LYMPHOMA, Blood, 90(10), 1997, pp. 1533-1533
Authors:
LAZZARINO M
ORLANDI E
ASTORI C
PAULLI M
MAGRINI U
BERNASCONI C
Citation: M. Lazzarino et al., A LOW SERUM BETA-2-MICROGLOBULIN LEVEL DESPITE BULKY TUMOR IS A CHARACTERISTIC FEATURE OF PRIMARY MEDIASTINAL (THYMIC) LARGE B-CELL LYMPHOMA - IMPLICATIONS FOR SEROLOGIC STAGING, European journal of haematology, 57(4), 1996, pp. 331-333
Authors:
ROSSO R
CASTELLO A
COLOSINI G
ASTORI C
LAZZARINO M
MAGRINI U
Citation: R. Rosso et al., SPLENIC MARGINAL ZONE CELL LYMPHOMA INVOLVING LIVER AND BONE-MARROW -REPORT OF A CASE WITH PROTRACTED FOLLOW-UP SHOWING PROGRESSIVE DISAPPEARANCE OF THE LYMPHOMA AFTER SPLENECTOMY, Haematologica, 81(1), 1996, pp. 44-46
Authors:
LAZZARINO M
ORLANDI E
ASTORI C
KLERSY C
BRUSAMOLINO E
CORSO A
BELLIO L
GARGANTINI L
MORRA E
BERNASCONI C
Citation: M. Lazzarino et al., SERUM A-125 IS OF CLINICAL-VALUE IN THE STAGING AND FOLLOW-UP OF NON-HODGKINS-LYMPHOMA (NHL) - CORRELATION WITH DISEASE-ACTIVITY AND OTHER PROGNOSTIC PARAMETERS, Blood, 88(10), 1996, pp. 884-884
Authors:
CORSO A
LAZZARINO M
MORRA E
MERANTE S
ASTORI C
BERNASCONI P
BONI M
BERNASCONI C
Citation: A. Corso et al., CHRONIC MYELOGENOUS LEUKEMIA AND EXPOSURE TO IONIZING RADIATION - A RETROSPECTIVE STUDY OF 443 PATIENTS, Annals of hematology, 70(2), 1995, pp. 79-82
Authors:
BRUSAMOLINO E
ORLANDI E
CANEVARI A
MORRA E
CASTELLI G
ALESSANDRINO EP
PAGNUCCO G
BERNASCONI P
ASTORI C
LAZZARINO M
BERNASCONI C
Citation: E. Brusamolino et al., RESULTS OF CAV REGIMEN (CCNU, MELPHALAN, AND VP-16) AS 3RD-LINE SALVAGE THERAPY FOR HODGKINS-DISEASE, Annals of oncology, 5(5), 1994, pp. 427-432
Authors:
BRUSAMOLINO E
ORLANDI E
MORRA E
CASTELLI G
PAGNUCCO G
LIVRAGHI A
ASTORI C
SANTAGOSTINO A
LAZZARINO M
BERNASCONI C
Citation: E. Brusamolino et al., ANALYSIS OF LONG-TERM RESULTS AND PROGNOSTIC FACTORS AMONG 138 PATIENTS WITH ADVANCED HODGKINS-DISEASE TREATED WITH THE ALTERNATING MOPP ABVD CHEMOTHERAPY, Annals of oncology, 5, 1994, pp. 190000053-190000057
Authors:
BRUSAMOLINO E
LAZZARINO M
ORLANDI E
CANEVARI A
MORRA E
CASTELLI G
ALESSANDRINO EP
PAGNUCCO G
ASTORI C
LIVRAGHI A
CORBELLA F
FRANCHINI P
BERNASCONI C
Citation: E. Brusamolino et al., EARLY-STAGE HODGKINS-DISEASE - LONG-TERM RESULTS WITH RADIOTHERAPY ALONE OR COMBINED RADIOTHERAPY AND CHEMOTHERAPY, Annals of oncology, 5, 1994, pp. 190000101-190000106
Authors:
BERNASCONI P
ALESSANDRINO EP
BONI M
BONFICHI M
MORRA E
LAZZARINO M
CAMPAGNOLI C
ASTORI C
Citation: P. Bernasconi et al., KARYOTYPE IN MYELODYSPLASTIC SYNDROMES - RELATIONS TO MORPHOLOGY, CLINICAL EVOLUTION, AND SURVIVAL, American journal of hematology, 46(4), 1994, pp. 270-277
Authors:
LAZZARINO M
ORLANDI E
PAULLI M
BOVERI E
MORRA E
BRUSAMOLINO E
KINDL S
ROSSO R
ASTORI C
BUONANNO MC
MAGRINI U
BERNASCONI C
Citation: M. Lazzarino et al., PRIMARY MEDIASTINAL B-CELL LYMPHOMA WITH SCLEROSIS - AN AGGRESSIVE TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES, Journal of clinical oncology, 11(12), 1993, pp. 2306-2313